U.S. President Donald Trump signed an executive order to revive the “most favored nation” drug pricing policy, aiming to slash U.S. prescription costs by tying them to the lowest prices paid abroad.
Trump Signs Order to Slash Medicine Prices by Up to 90%
The order, broader than a previous version, applies to the commercial market, Medicare, and Medicaid, targeting high-cost drugs like GLP-1s. Trump claimed prices could drop by up to 90%, though analysts remain skeptical about feasibility without congressional approval.
While AARP praised the move, PhRMA warned it could stifle innovation. Despite uncertainties, pharmaceutical stocks rose, signaling market doubts about the policy’s immediate impact.
Follow us on:
Read More News at #latestmalaysia #BusinessNews and #WorldFuture
